Torii Pharmaceutical Co (TRXPF) Stock Statistics & Valuation Metrics

Torii Pharmaceutical Co has a market cap or net worth of $1.24B. The enterprise value is ―.

Torii Pharmaceutical Co has 28,800,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Torii Pharmaceutical Co’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Torii Pharmaceutical Co is ―. Torii Pharmaceutical Co’s PEG ratio is ―.

In the last 12 months, Torii Pharmaceutical Co had revenue of 54.64B and earned 4.12B in profits. Earnings per share was 146.57.

In the last 12 months, operating cash flow was 474.00M and capital expenditures 0.00, giving a free cash flow of 474.00M billion.

Torii Pharmaceutical Co pays an annual dividend of $0.418, resulting in a dividend yield of 2.13%

Torii Pharmaceutical Co upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.

Torii Pharmaceutical Co as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Torii Pharmaceutical Co has paid 1.47B in taxes.

Torii Pharmaceutical Co EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Torii Pharmaceutical Co has $45.93B in cash and marketable securities with ¥302.00M in debt, giving a net cash position of -$45.62B billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Torii Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―